EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes

Emma M Jones, Caren Sourij, Martin Stradner, Peter Schlenke, Nazanin Sereban, Othmar Moser, Rachael Quinlan, Charlotte-Eve Short, Benjamin H L Harris, Michael Fertleman, Graham P Taylor, Nick Oliver und 2 weitere

European Journal of Immunology · 2025

DOI: 10.1002/eji.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Emma M Jones und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Interleukin-10, SARS-CoV-2. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 and type 2 diabetes are associated with increased severity and mortality from respiratory virus infections. Vaccination in the general population significantly reduces the risk of severe respiratory viral infection and triggers a strong, polyfunctional, and lasting T cell response in healthy individuals. However, vaccine effectiveness in people with type 1 diabetes is unclear. Here, we studied the magnitude and functional characteristics of vaccine‐specific CD4 + and CD8 + T cell responses to vaccination in people with type 1 and type 2 diabetes and compared them to those of people living without diabetes, using the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine as a model. We found defects in both CD4 + and CD8 + T cell memory maintenance and the functionality of the vaccine‐specific T cells in people with diabetes compared with people without. In those individuals with type 1 and type 2 diabetes who harbored detectable vaccine‐specific T cells, they displayed an unfocused, tolerogenic phenotype characterized by increased expression of IL‐10 and IL‐13 compared with people without diabetes. These results have implications for vaccination strategies for people with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Interleukin-10SARS-CoV-2CD8-Positive T-LymphocytesCOVID-19Interleukin-13COVID-19 VaccinesCD4-Positive T-LymphocytesHumansFemaleMaleMiddle AgedAdultVaccinationAgedImmunologic Memory

Stichwörter der Autor:innen

SARS‐CoV‐2T cellsdiabetesmemorytype 1 diabetesvaccination

Substanzen

Interleukin-10Interleukin-13COVID-19 VaccinesIL10 protein, humanIL13 protein, human

Autor:innen und Institutionen

  • Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
  • Division of Cardiology, Medical University of Graz, Austria.
  • Division of Rheumatology and Immunology, Medical University of Graz, Austria.
  • Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Austria.
  • University of Bayreuth, Bayreuth, Germany.
  • Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, Austria.

Förderung

  • Diabetes UK
  • Austrian Science Fund

Zitieren

APA

Jones, E. M., Sourij, C., Stradner, M., Schlenke, P., Sereban, N., Moser, O., Quinlan, R., Short, C. E., Harris, B. H. L., Fertleman, M., Taylor, G. P., Oliver, N., Sourij, H., & Dominguez-Villar, M. (2025). IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes. European Journal of Immunology. https://doi.org/10.1002/eji.70112

Vancouver

Jones EM, Sourij C, Stradner M, Schlenke P, Sereban N, Moser O, et al. IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes. European Journal of Immunology. 2025. doi:10.1002/eji.70112

BibTeX
@article{Jones2025,
  author = {Jones, Emma M and Sourij, Caren and Stradner, Martin and Schlenke, Peter and Sereban, Nazanin and Moser, Othmar and Quinlan, Rachael and Short, Charlotte-Eve and Harris, Benjamin H L and Fertleman, Michael and Taylor, Graham P and Oliver, Nick and Sourij, Harald and Dominguez-Villar, Margarita},
  title = {IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.70112}
}
Kostenlos starten →